Etripamil
Etripamil, sold under the brand name Cardamyst, is a medication used for the treatment of paroxysmal supraventricular tachycardia. It is a calcium channel blocker. It is used as a nasal spray. Etripamil was approved for medical use in the United States in December 2025.
Wikipedia contributors, "Etripamil", Wikipedia, revision 1382115703, retrieved 20 November 2026, source, CC BY-SA 4.0.